Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.26 USD
Change Today 0.00 / 0.00%
Volume 0.0
LIXT On Other Exchanges
As of 8:10 PM 08/25/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

John S. Kovach M.D.

Founder, Chairman of the Board, Chief Executive Officer, President, Chief Financial Officer and Principal Accounting Officer,Lixte Biotechnology Holdings, Inc.
AgeTotal Calculated CompensationThis person is connected to 6 board members in 1 different organizations across 1 different industries.

See Board Relationships
As of Fiscal Year 2014


Dr. John S. Kovach, M.D, founded Lixte Biotechnology Holdings Inc. in August 2005 and serves as its Chairman, Chief Executive Officer, President, Principal Financial Officer and Principal Accounting Officer. From 1994 to 2000, Dr. Kovach served as an Executive Vice President of Medical and Scientific Affairs, City of Hope National Medical Center in Los Angeles, California. From 1976 to 1994, he served as a Consultant in Oncology and a Director of the Cancer Pharmacology ...

Read Full Background

Corporate Headquarters*

248 Route 25A, No. 2
East Setauket, New York 11733

United States

Phone: 631-942-7959
Fax: --

Board Members Memberships*

Founder, Chairman of the Board, Chief Executive Officer, President, Chief Financial Officer and Principal Accounting Officer


Princeton University
Columbia University College of Physicians & Surgeons in New York

Other Affiliations*

Annual Compensation*

Total Annual Compensation$60,000

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$60,000
Total Short Term Compensation$60,000
Total Calculated Compensation$60,000
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LIXT:US $0.26 USD 0.00


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LIXTE BIOTECHNOLOGY HOLDINGS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at